Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature

Summary

To demonstrate that an individualized, formula-based Genotropin regimen for children with Idiopathic Short Stature will lead to a targeted height gain (to reach the target of 10th percentile (%), or -1.3 SDS) during 24 months of treatment. The endpoint at 4 years is to explore treatment efficiency over four years of two formula-based dose regimens (sub-arms) compared to standard treatment

Timeline

Start

2006-12

Primary completion

2012-08

Completion

2012-08

Drugs

Indications